We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.1%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$5.88B
AUM Growth
+$1.01B
Cap. Flow
+$924M
Cap. Flow %
15.72%
Top 10 Hldgs %
9.87%
Holding
605
New
228
Increased
122
Reduced
115
Closed
133

Sector Composition

Rank Sector Weight
1 Healthcare 14.61%
2 Financials 12.78%
3 Industrials 11.19%
4 Technology 9.23%
5 Consumer Discretionary 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWH icon
376
Sportsman's Warehouse
SPWH
$46M
$1.28M 0.02%
175,000
-75,000
-30% -$539K
QNST icon
377
QuinStreet
QNST
$1.21B
$1.28M 0.02%
210,491
+92,694
+79% +$425K
OKE icon
378
Oneok
OKE
$54.5B
$1.24M 0.02%
+24,991
New +$1.38M
SUPN icon
379
Supernus Pharmaceuticals
SUPN
$2.77B
$1.23M 0.02%
148,001
+48,454
+49% +$407K
BBEP
380
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
$1.23M 0.02%
+175,000
New +$2.4M
YDLE
381
DELISTED
YODLEE INC COMMON STOCK
YDLE
$1.22M 0.02%
+100,000
New +$1.29M
DGX icon
382
Quest Diagnostics
DGX
$26.3B
$1.21M 0.02%
+17,995
New +$1.14M
FAF icon
383
First American
FAF
$7.58B
$1.17M 0.02%
+34,465
New +$1.06M
ESI icon
384
Element Solutions
ESI
$9.23B
$1.16M 0.02%
+50,000
New +$1.24M
HXL icon
385
Hexcel
HXL
$7.82B
$1.16M 0.02%
+27,833
New +$1.15M
ADMS
386
DELISTED
Adamas Pharmaceuticals
ADMS
$1.14M 0.02%
65,515
+43,537
+198% +$661K
BLCM
387
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.13M 0.02%
+4,909
New +$1.05M
TBCH
388
Turtle Beach Corp
TBCH
$277M
$1.11M 0.02%
87,024
-8,587
-9% -$164K
TAST
389
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.1M 0.02%
144,643
+3,240
+2% +$24.2K
PKT
390
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$1.1M 0.02%
+152,419
New +$1.09M
TYC
391
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$1.09M 0.02%
+23,835
New +$1.06M
TEN
392
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$1.08M 0.02%
+19,059
New +$1.03M
USDP
393
DELISTED
USD PARTNERS LP
USDP
$1.06M 0.02%
+75,000
New +$1.15M
RTN
394
DELISTED
Raytheon Company
RTN
$1.06M 0.02%
+9,822
New +$1.01M
TCPI
395
DELISTED
TCP International Hldgs Ltd.
TCPI
$1.04M 0.02%
169,041
-156,060
-48% -$955K
ITCI
396
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.02M 0.02%
57,853
-2,142
-4% -$33.5K
ZION icon
397
Zions Bancorporation
ZION
$10.3B
$1.01M 0.02%
+35,314
New +$996K
ARGS
398
DELISTED
Argos Therapeutics, Inc.
ARGS
$1.01M 0.02%
5,035
+1,063
+27% +$191K
MHK icon
399
Mohawk Industries
MHK
$9.22B
$1M 0.02%
6,452
-233,120
-97% -$33.5M
MOBL
400
DELISTED
MobileIron, Inc.
MOBL
$996K 0.02%
100,000
-1,950
-2% -$18.5K

Similar funds

Alyeska Investment Group's Q4 2014 Portfolio in Review

As of Q4 2014, Alyeska Investment Group held 605 positions worth $5.88B, up 21% from $4.86B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Alyeska Investment Group deployed $924M of net new capital in Q4 2014, opening 228 new positions and adding to 122 existing holdings. Its largest new stake was Halliburton: 1,234,449 shares worth $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Bloomin' Brands, an estimated $42.5M trimmed.

  • Alyeska Investment Group's largest Q4 2014 buy was Halliburton: 1,234,449 shares worth $48.6M.
  • Alyeska Investment Group added most to HD Supply Holdings, Inc. in Q4 2014, an estimated $50.6M increase.
  • Alyeska Investment Group's biggest Q4 2014 reduction was Bloomin' Brands, cutting an estimated $42.5M.
  • Alyeska Investment Group fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $61.6M.
  • Alyeska Investment Group's ten largest holdings make up 9.9% of its $5.88B portfolio in Q4 2014.
  • Alyeska Investment Group opened 228 new positions and closed 133 in Q4 2014.
  • Alyeska Investment Group's portfolio value rose 21% quarter-over-quarter to $5.88B.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.